Co-Diagnostics ROA 2017-2023 | CODX
Current and historical return on assets (ROA) values for Co-Diagnostics (CODX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Co-Diagnostics ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2023-12-31 | $-0.04B | $0.10B | -33.18% |
| 2023-09-30 | $-0.04B | $0.11B | -37.23% |
| 2023-06-30 | $-0.04B | $0.11B | -30.34% |
| 2023-03-31 | $-0.03B | $0.12B | -23.32% |
| 2022-12-31 | $-0.01B | $0.12B | -9.29% |
| 2022-09-30 | $0.02B | $0.15B | 9.38% |
| 2022-06-30 | $0.03B | $0.16B | 18.09% |
| 2022-03-31 | $0.04B | $0.17B | 30.25% |
| 2021-12-31 | $0.04B | $0.16B | 32.80% |
| 2021-09-30 | $0.04B | $0.11B | 48.00% |
| 2021-06-30 | $0.05B | $0.09B | 62.67% |
| 2021-03-31 | $0.05B | $0.08B | 84.55% |
| 2020-12-31 | $0.04B | $0.07B | 92.97% |
| 2020-09-30 | $0.03B | $0.06B | 96.55% |
| 2020-06-30 | $0.01B | $0.04B | 61.54% |
| 2020-03-31 | $-0.01B | $0.02B | -77.42% |
| 2019-12-31 | $-0.01B | $0.00B | -141.18% |
| 2019-09-30 | $-0.01B | $0.00B | -141.18% |
| 2019-06-30 | $-0.01B | $0.01B | -150.00% |
| 2019-03-31 | $-0.01B | $0.01B | -184.62% |
| 2018-12-31 | $-0.01B | $0.00B | -240.00% |
| 2018-09-30 | $-0.01B | $0.00B | -184.62% |
| 2018-06-30 | $-0.01B | $0.00B | -200.00% |
| 2018-03-31 | $-0.01B | $0.00B | -228.57% |
| 2017-12-31 | $-0.01B | $0.01B | -290.91% |
| 2017-06-30 | $-0.00B | $0.00B | inf% |
| 2017-03-31 | $-0.00B | $0.00B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.036B | $0.007B |
| Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.512B | 15.50 |
| Cencora (COR) | United States | $47.702B | 19.04 |
| ICON (ICLR) | Ireland | $23.778B | 23.45 |
| DiDi Global (DIDIY) | China | $21.472B | 0.00 |
| Avantor (AVTR) | United States | $16.347B | 22.52 |
| Viatris (VTRS) | United States | $13.496B | 3.85 |
| CochLear (CHEOY) | $13.392B | 0.00 | |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.462B | 0.00 |
| Revvity (RVTY) | United States | $12.459B | 21.69 |
| Charles River Laboratories (CRL) | United States | $11.682B | 21.29 |
| Medpace Holdings (MEDP) | United States | $11.526B | 41.89 |
| Solventum (SOLV) | United States | $10.730B | 0.00 |
| Natera (NTRA) | United States | $10.298B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.940B | 51.85 |
| Bausch + Lomb (BLCO) | Canada | $5.145B | 19.78 |
| Doximity (DOCS) | United States | $4.595B | 34.21 |
| Organon (OGN) | United States | $4.555B | 4.41 |
| PACS (PACS) | United States | $3.551B | 0.00 |
| Progyny (PGNY) | United States | $3.143B | 52.74 |
| Sotera Health (SHC) | United States | $3.100B | 15.21 |
| Surgery Partners (SGRY) | United States | $3.017B | 28.03 |
| Life Times (LTH) | United States | $2.756B | 30.46 |
| GoodRx Holdings (GDRX) | United States | $2.643B | 133.80 |
| Premier (PINC) | United States | $2.538B | 9.29 |
| Agilon Health (AGL) | United States | $2.244B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.198B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.158B | 6.98 |
| BrightSpring Health Services (BTSG) | United States | $1.799B | 0.00 |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| Establishment Labs Holdings (ESTA) | $1.301B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.301B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.983B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.759B | 7.85 |
| Embecta (EMBC) | United States | $0.611B | 4.04 |
| InnovAge Holding (INNV) | United States | $0.537B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.519B | 0.00 |
| Enhabit (EHAB) | United States | $0.514B | 46.59 |
| Auna S.A (AUNA) | Luxembourg | $0.503B | 0.00 |
| CareDx (CDNA) | United States | $0.430B | 0.00 |
| MultiPlan (MPLN) | United States | $0.419B | 0.00 |
| Beauty Health (SKIN) | United States | $0.404B | 0.00 |
| LifeMD (LFMD) | United States | $0.392B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.388B | 0.00 |
| DocGo (DCGO) | United States | $0.372B | 59.50 |
| Sera Prognostics (SERA) | United States | $0.316B | 0.00 |
| ModivCare (MODV) | United States | $0.302B | 4.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.263B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.251B | 0.00 |
| Sharecare (SHCR) | United States | $0.235B | 0.00 |
| Biodesix (BDSX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.115B | 38.67 |
| Oncology Institute (TOI) | United States | $0.088B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.064B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
| NeueHealth (NEUE) | United States | $0.048B | 0.00 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |